Vaccine for modulating between T1 and T2 immune responses

Details for Australian Patent Application No. 2002309141 (hide)

Owner Biomira Inc.

Inventors Koganty, Rao R.; Krantz, Mark J.; Longenecker, Michael B.; Budzynski, Wladyslaw A.

Agent Griffith Hack

Pub. Number AU-B-2002309141

PCT Number PCT/IB02/02188

PCT Pub. Number WO2002/076485

Priority 60/278,698 27.03.01 US

Filing date 27 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 9 August 2007

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/015 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/06 (2006.01) Antiparasitic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/02 (2006.01) Peptides having more than 20 amino acids

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

C07K 14/445 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

C07K 17/06 (2006.01) Carrier-bound or immobilised peptides

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/278,698 27.03.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002309141

16 March 2006 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from Biomira, Inc. to Biomira Inc.

9 August 2007 Application Accepted

  Published as AU-B-2002309141

6 December 2007 Standard Patent Sealed

6 August 2009 Assignment Registered

  Biomira Inc. The patent has been assigned to Oncothyreon Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002309142-NEW BIOPOLYMERS OBTAINED BY SOLID STATE IRRADIATION IN AN UNSATURATED GASEOUS ATMOSPHERE

2002309140-CONJUGATE VACCINE COMPOSED OF THE POLYSACCHARIDE MOIETY OF THE LIPOPOLYSACCHARIDE OF VIBRIO CHOLERAE 0139 BOUND TO TETANUS TOXOID